151 related articles for article (PubMed ID: 17389307)
1. Hereditary hemochromatosis genotypes and risk of ischemic stroke.
Ellervik C; Tybjaerg-Hansen A; Appleyard M; Sillesen H; Boysen G; Nordestgaard BG
Neurology; 2007 Mar; 68(13):1025-31. PubMed ID: 17389307
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study.
Ellervik C; Tybjaerg-Hansen A; Grande P; Appleyard M; Nordestgaard BG
Circulation; 2005 Jul; 112(2):185-93. PubMed ID: 15998685
[TBL] [Abstract][Full Text] [Related]
3. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
[TBL] [Abstract][Full Text] [Related]
4. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
5. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults.
Pezzini A; Grassi M; Del Zotto E; Lodigiani C; Ferrazzi P; Spalloni A; Patella R; Giossi A; Volonghi I; Iacoviello L; Magoni M; Rota LL; Rasura M; Padovani A
Neurology; 2009 Sep; 73(9):717-23. PubMed ID: 19720979
[TBL] [Abstract][Full Text] [Related]
6. Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis.
Sherrington CA; Knuiman MW; Divitini ML; Bartholomew HC; Cullen DJ; Olynyk JK
J Gastroenterol Hepatol; 2006 Mar; 21(3):595-8. PubMed ID: 16638105
[TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.
Hruskovicová H; Milanez T; Kobal J; Potisk KP; Petrovic D; Peterlin B
Med Sci Monit; 2005 Jul; 11(7):BR248-52. PubMed ID: 15990686
[TBL] [Abstract][Full Text] [Related]
8. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
9. Searching for hereditary hemochromatosis.
Laudicina RJ
Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
[TBL] [Abstract][Full Text] [Related]
10. Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population.
van Rijn MJ; Slooter AJ; Schut AF; Isaacs A; Aulchenko YS; Snijders PJ; Kappelle LJ; van Swieten JC; Oostra BA; van Duijn CM
Neurology; 2005 Oct; 65(8):1203-9. PubMed ID: 16162858
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.
Ellervik C; Birgens H; Tybjaerg-Hansen A; Nordestgaard BG
Hepatology; 2007 Oct; 46(4):1071-80. PubMed ID: 17828789
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration.
Zamboni P; Tognazzo S; Izzo M; Pancaldi F; Scapoli GL; Liboni A; Gemmati D
J Vasc Surg; 2005 Aug; 42(2):309-14. PubMed ID: 16102632
[TBL] [Abstract][Full Text] [Related]
13. Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.
Kostulas N; Markaki I; Kostulas V; Hillert J; Kostulas K
Scand J Immunol; 2009 Nov; 70(5):475-80. PubMed ID: 19874552
[TBL] [Abstract][Full Text] [Related]
14. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
15. Detection of the C282Y and H63D polymorphisms associated with hereditary hemochromatosis using the ABI 7500 fast real time PCR platform.
Tafe LJ; Belloni DR; Tsongalis GJ
Diagn Mol Pathol; 2007 Jun; 16(2):112-5. PubMed ID: 17525682
[TBL] [Abstract][Full Text] [Related]
16. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
[TBL] [Abstract][Full Text] [Related]
17. HFE mutations and risk of coronary heart disease in middle-aged women.
van der A DL; Peeters PH; Grobbee DE; Roest M; Marx JJ; Voorbij HM; van der Schouw YT
Eur J Clin Invest; 2006 Oct; 36(10):682-90. PubMed ID: 16968463
[TBL] [Abstract][Full Text] [Related]
18. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country.
Bauduer F; Scribans C; Degioanni A; Renoux M; Dutour O
Ann Hematol; 2005 Feb; 84(2):99-102. PubMed ID: 15503019
[TBL] [Abstract][Full Text] [Related]
19. HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women.
van der A DL; Peeters PH; Grobbee DE; Roest M; Voorbij HA; van der Schouw YT
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):60-8. PubMed ID: 16399493
[TBL] [Abstract][Full Text] [Related]
20. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction.
Gromadzka G; Baranska-Gieruszczak M; Sarzynska-Dlugosz I; Ciesielska A; Czlonkowska A
Acta Neurol Scand; 2007 Dec; 116(6):392-8. PubMed ID: 17986098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]